1. Home
  2. THMO

THMO

ThermoGenesis Holdings Inc.

Logo ThermoGenesis Holdings Inc.

Industrials

Medical Specialities

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.

Founded: 1986 Country:
United States
United States
Employees: N/A City: RANCHO CORDOVA
Market Cap: 2.5M IPO Year: N/A
Target Price: $5.00 AVG Volume (30 days): 86.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.59 EPS Growth: N/A
52 Week Low/High: $0.36 - $2.98 Next Earning Date: 05-13-2024
Revenue: $9,445,000 Revenue Growth: -9.90%
Revenue Growth (this year): 10.76% Revenue Growth (next year): 48.46%

Share on Social Networks: